PEOPLE - Changes at Chiron (US):
This article was originally published in Clinica
Executive Summary
Chiron, the US parent company of Chiron Diagnostics, has appointed James Sulat chief financial officer. He was previously with Stanford Health Services. In addition, Sean Lance of Glaxo Wellcome will succeed Dr Edward Penhoet as CEO. De Penhoet will assume the role of vice-chairman.